Kolean J. Chad's most recent trade in Cellectar Biosciences Inc was a trade of 5,000 Warrants done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellectar Biosciences Inc | Kolean J. Chad | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Jul 2025 | 5,000 | 5,000 | - | - | Warrants | |
| Cellectar Biosciences Inc | Kolean Chad J. | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.99 per share. | 02 Jul 2025 | 5,000 | 6,418 (0%) | 0% | 5.0 | 24,950 | Common Stock |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 290,000 | 290,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 290,000 | 290,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Kolean Chad J. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 104,000 | 104,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | J. Kolean Chad | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 42,554 | 42,578 (0%) | 0% | 0 | Common Stock | |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 104,000 | 104,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 150,000 | 150,000 | - | - | Stock option (right to buy) |